Chimeric antigen receptor T cells (CAR-T cells) are often hindered by the concurrent challenges of variable antigen expression patterns and immunosuppressive tumor microenvironments. A new approach enhances CAR-T cells by coexpressing bacterial enzymes that activate prodrugs in high concentrations at the disease site.
References
Gardner, T. J. et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-021-00932-1 (2021).
Majzner, R. G. & Mackall, C. L. Cancer Discov. 8, 1219–1226 (2018).
Hyrenius-Wittsten, A. & Roybal, K. T. Trends. Cancer 5, 583–592 (2019).
Gardner, T. J. et al. Cancers 12, 2175 (2020).
Sharma, S. K. & Bagshawe, K. D. Expert Opin. Biol. Th. 17, 1–13 (2016).
Roybal, K. T. et al. Cell 167, 419–432.e16 (2016).
Choi, B. D. et al. Nat. Biotechnol. 37, 1049–1058 (2019).
Sukumaran, S. et al. Cancer Discov. 8, 972–987 (2018).
Huang, X. et al. Nat. Nanotechnol. 16, 214–223 (2021).
Park, A. K. et al. Science Transl. Med. 12, eaaz1863 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Vincent, R., Danino, T. CAR-T cells SEAK help from enzymes. Nat Chem Biol 18, 122–123 (2022). https://doi.org/10.1038/s41589-021-00933-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41589-021-00933-0
- Springer Nature America, Inc.
This article is cited by
-
Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development
Signal Transduction and Targeted Therapy (2023)